Calidi Biotherapeutics appoints Dr. Guy Travis Clifton as Chief Medical Officer, Consultant and Advisor

Calidi Biotherapeutics, Inc.

Appointment effective April 8, 2025; one-year term with monthly consulting fee of $20,833.33.
Dr. Clifton is a practicing surgical oncologist with 17+ years experience, previously CMO at Parthenon Therapeutics.
Appointment coincides with recently filed IND for CLD-201 dose escalation trial in solid tumors.
Dr. Clifton has over 80 peer-reviewed publications and served as U.S. Army Colonel with four Afghanistan deployments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.